Analystreport

Repligen Co. (NASDAQ: RGEN) had its price target lowered by analysts at Stifel Nicolaus from $225.00 to $210.00.

Repligen Corporation  (RGEN) 
Last repligen corporation earnings: 2/20 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: repligen.com/investors